These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase. Spada A; Arosio M; Bochicchio D; Bazzoni N; Vallar L; Bassetti M; Faglia G J Clin Endocrinol Metab; 1990 Dec; 71(6):1421-6. PubMed ID: 1977758 [TBL] [Abstract][Full Text] [Related]
3. Clinical and biochemical characteristics of acromegalic patients harboring gsp-positive and gsp-negative pituitary tumors. Adams EF; Brockmeier S; Friedmann E; Roth M; Buchfelder M; Fahlbusch R Neurosurgery; 1993 Aug; 33(2):198-203; discussion 203. PubMed ID: 8396223 [TBL] [Abstract][Full Text] [Related]
4. Detection of gsp oncogene in growth hormone-secreting pituitary adenomas and the study of clinical characteristics of acromegalic patients with gsp-positive pituitary tumors. Shi Y; Tang D; Deng J; Su C Chin Med J (Engl); 1998 Oct; 111(10):891-4. PubMed ID: 11189233 [TBL] [Abstract][Full Text] [Related]
5. Glycoprotein hormone alpha-subunit production in somatotroph adenomas with and without Gs alpha mutations. Harris PE; Alexander JM; Bikkal HA; Hsu DW; Hedley-Whyte ET; Klibanski A; Jameson JL J Clin Endocrinol Metab; 1992 Sep; 75(3):918-23. PubMed ID: 1517386 [TBL] [Abstract][Full Text] [Related]
6. Characteristics of gsp-positive growth hormone-secreting pituitary tumors in Korean acromegalic patients. Yang I; Park S; Ryu M; Woo J; Kim S; Kim J; Kim Y; Choi Y Eur J Endocrinol; 1996 Jun; 134(6):720-6. PubMed ID: 8766942 [TBL] [Abstract][Full Text] [Related]
7. GSPalpha mutations in Mexican patients with acromegaly: potential impact on long term prognosis. Mendoza V; Sosa E; Espinosa-de-Los-Monteros AL; Salcedo M; Guinto G; Cheng S; Sandoval C; Mercado M Growth Horm IGF Res; 2005 Feb; 15(1):28-32. PubMed ID: 15701569 [TBL] [Abstract][Full Text] [Related]
8. Analysis of GNAS mutations in 60 growth hormone secreting pituitary tumors: correlation with clinical and pathological characteristics and surgical outcome based on highly sensitive GH and IGF-I criteria for remission. Freda PU; Chung WK; Matsuoka N; Walsh JE; Kanibir MN; Kleinman G; Wang Y; Bruce JN; Post KD Pituitary; 2007; 10(3):275-82. PubMed ID: 17594522 [TBL] [Abstract][Full Text] [Related]
9. Activating mutations of the Gs alpha gene are associated with low levels of Gs alpha protein in growth hormone-secreting tumors. Ballaré E; Mantovani S; Lania A; Di Blasio AM; Vallar L; Spada A J Clin Endocrinol Metab; 1998 Dec; 83(12):4386-90. PubMed ID: 9851782 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of Gs alpha mutations in Korean patients with pituitary adenomas. Kim HJ; Kim MS; Park YJ; Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Jung HW; Han DH; Lee HS; Chi JG J Endocrinol; 2001 Feb; 168(2):221-6. PubMed ID: 11182759 [TBL] [Abstract][Full Text] [Related]
11. Mutations in the alpha subunit of the stimulatory regulatory protein of adenylyl cyclase (Gs) in human GH-secreting pituitary adenomas. Biochemical, clinical, and morphological aspects. Spada A; Arosio M; Bassetti M; Vallar L; Clementi E; Bazzoni N Pathol Res Pract; 1991 Jun; 187(5):567-70. PubMed ID: 1923949 [TBL] [Abstract][Full Text] [Related]
12. Analysis of the Gs alpha gene in growth hormone-secreting pituitary adenomas by the polymerase chain reaction-direct sequencing method using paraffin-embedded tissues. Hosoi E; Yokogoshi Y; Hosoi E; Horie H; Sano T; Yamada S; Saito S Acta Endocrinol (Copenh); 1993 Oct; 129(4):301-6. PubMed ID: 8237246 [TBL] [Abstract][Full Text] [Related]
13. Activating mutations of the Gs alpha-gene in nonfunctioning pituitary tumors. Tordjman K; Stern N; Ouaknine G; Yossiphov Y; Razon N; Nordenskjöld M; Friedman E J Clin Endocrinol Metab; 1993 Sep; 77(3):765-9. PubMed ID: 8396579 [TBL] [Abstract][Full Text] [Related]
14. Acromegaly in a family without a mutation in the menin gene. Ackermann F; Krohn K; Windgassen M; Buchfelder M; Fahlbusch R; Paschke R Exp Clin Endocrinol Diabetes; 1999; 107(1):93-6. PubMed ID: 10077364 [TBL] [Abstract][Full Text] [Related]
15. Rare mutations of the Gs alpha subunit gene in human endocrine tumors. Mutation detection by polymerase chain reaction-primer-introduced restriction analysis. Yoshimoto K; Iwahana H; Fukuda A; Sano T; Itakura M Cancer; 1993 Aug; 72(4):1386-93. PubMed ID: 8339229 [TBL] [Abstract][Full Text] [Related]
16. Identification of G protein alpha subunit mutations in human growth hormone (GH)- and GH/prolactin-secreting pituitary tumors by single-strand conformation polymorphism (SSCP) analysis. Drews RT; Gravel RA; Collu R Mol Cell Endocrinol; 1992 Sep; 87(1-3):125-9. PubMed ID: 1446784 [TBL] [Abstract][Full Text] [Related]
17. The glucose-dependent insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cells. Occhi G; Losa M; Albiger N; Trivellin G; Regazzo D; Scanarini M; Monteserin-Garcia JL; Fröhlich B; Ferasin S; Terreni MR; Fassina A; Vitiello L; Stalla G; Mantero F; Scaroni C J Neuroendocrinol; 2011 Jul; 23(7):641-9. PubMed ID: 21554434 [TBL] [Abstract][Full Text] [Related]
18. Clinical correlates in acromegalic patients with pituitary tumors expressing GSP oncogenes. Buchfelder M; Fahlbusch R; Merz T; Symowski H; Adams EF Pituitary; 1999 May; 1(3-4):181-5. PubMed ID: 11081196 [TBL] [Abstract][Full Text] [Related]
19. G-protein oncogenes in acromegaly. Spada A; Vallar L Horm Res; 1992; 38(1-2):90-3. PubMed ID: 1306524 [TBL] [Abstract][Full Text] [Related]
20. Pituitary adenomas: screening for G alpha q mutations. Oyesiku NM; Evans CO; Brown MR; Blevins LS; Tindall GT; Parks JS J Clin Endocrinol Metab; 1997 Dec; 82(12):4184-8. PubMed ID: 9398737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]